Gemtuzumab ozogamicin s Midostaurinem v intenzivní léčbě CD33/FLT3+ AML – aktualizovaná data.

Investor logo

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Title in English Gemtuzumab ozogamicin with Midostaurin in the intensive treatment of CD33/FLT3+ AML - updated data
Authors

WEINBERGEROVÁ Barbora ČERŇAN M. SZOTKOWSKI Tomáš SEMERÁD Lukáš KABUT T. NAVRÁTILOVÁ J. PODSTAVKOVÁ N. PROCHÁZKOVÁ Jiřina JEŽÍŠKOVÁ Ivana KLEMEŠOVÁ Iveta FOLTA A. MAYER Jiří

Year of publication 2023
Type Conference abstract
MU Faculty or unit

Faculty of Medicine

Citation
Description Gemtuzumab ozogamicin with Midostaurin in the intensive treatment of CD33/FLT3+ AML - updated data - conference abstract.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info